Trial Profile
The Paliperidone ER Outcomes Study of Schizophrenia Patients in Typical Clinical Practice (The POST Study).
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 31 Aug 2012
Price :
$35
*
At a glance
- Drugs Paliperidone (Primary) ; Aripiprazole; Olanzapine; Quetiapine; Risperidone; Ziprasidone
- Indications Schizophrenia
- Focus Therapeutic Use
- Acronyms POST
- Sponsors Ortho-McNeil
- 01 May 2012 Actual patient number is 43 according to ClinicalTrials.gov.
- 01 May 2012 Actual end date (Oct 2007) added as reported by ClinicalTrials.gov.
- 14 Dec 2008 Status changed from active, no longer recruiting to discontinued as reported by ClinicalTrials.gov.